patients using oral contraceptives should consider backup contraception for 4 weeks after tirzepatide initiation or dose escalation
Regarding approved uses, tesofensine is specifically used to treat obesity, while semaglutide is indicated for both type 2 diabetes and obesity management
In addition, researchers determined that participants taking retatrutide had not yet reached a weight loss plateau at 80 weeks, meaning continued treatment would likely produce further weight loss
BPC-157 may help manage any gastrointestinal side effects through its protective effects on gut mucosa
Biochem Biophys Res Commun 159(2):741747 Pacheco BP, Crajoinas RO, Couto GK, Davel AP, Lessa LM, Rossoni LV et al (2011) Dipeptidyl peptidase IV inhibition attenuates blood pressure rising in young spontaneously hypertensive rats